TRDSi002-A
General
Cell Line |
|
hPSCreg name | TRDSi002-A |
Cite as: | TRDSi002-A (RRID:CVCL_UL00) |
Cell line type | Human induced pluripotent stem cell (hiPSC) |
Similar lines |
TRDSi002-A-1 (TRDS-Cardio-ArcLight) |
Last update | 22nd May 2019 |
User feedback | |
Provider |
|
Generator | Technion Research and Development Foundation (TRDS) |
External Databases |
|
BioSamples | SAMEA104620767 |
Cellosaurus | CVCL_UL00 |
Wikidata | Q98133533 |
General Information |
|
* Is the cell line readily obtainable for third parties? |
No |
Subclones |
Donor Information
General Donor Information |
|
Sex | male |
Phenotype and Disease related information (Donor) |
|
Diseases | No disease was diagnosed.
|
External Databases (Donor) |
|
BioSamples | SAMEA104620768 |
Ethics
Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? | Yes |
Was the consent voluntarily given? | Yes |
Has the donor been informed that participation will not directly influence their personal treatment? | Yes |
Can you provide us with a copy of the Donor Information Sheet provided to the donor? | Yes |
Please provide contact information of the holder of the original Donor Information Sheet. | |
Do you (Depositor/Provider) hold the original Donor Consent Form? | No |
If you do not hold the Donor Consent Form, do you know who does? | No |
Please provide the contact information | |
Alternatives to consent | |
Alternative consent approval number | |
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. | pseudonymised |
Does consent explicitly allow the derivation of pluripotent stem cells? | Yes |
Does consent expressly prevent the derivation of pluripotent stem cells? | No |
Details on restriction to research project | |
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? | No |
How may genetic information associated with the cell line be accessed? | No information |
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? | No |
Please describe how access is provided: | |
Contact data, institution, or website: | |
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? | Yes |
Name of accrediting authority involved? | Helsinki Committee of the Rambam Health Care Campus, Haifa, Israel |
Approval number | 0170-09-RMB |
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the PROPOSED PROJECT, involving use of donated embryo/tissue or derived cells? | Yes |
Name of accrediting authority involved? | Helsinki Committee of the Rambam Health Care Campus, Haifa, Israel |
Approval number | 0170-09-RMB |
Please describe: | |
Further constraints on use | |
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? | |
Constraints for use or distribution |
hIPSC Derivation
General |
|
Source cell type |
A connective tissue cell which secretes an extracellular matrix rich in collagen and other macromolecules. Flattened and irregular in outline with branching processes; appear fusiform or spindle-shaped.; These cells may be vimentin-positive, fibronectin-positive, fsp1-positive, MMP-1-positive, collagen I-positive, collagen III-positive, and alpha-SMA-negative.
|
Source cell type (free text) | Fibroblasts from skin biopsy |
Reprogramming method |
|
Vector type | Integrating |
Vector | Virus (Retrovirus) |
Genes | |
Is the used vector excisable? |
Unknown |
Absence of reprogramming vector(s)? |
Unknown |
Reprogramming vectors silenced? | |
Vector free reprogramming |
|
Other |
|
Derived under xeno-free conditions |
Unknown |
Derived under GMP? |
Unknown |
Available as clinical grade? |
Unknown |
Culture Conditions
Medium |
mTeSR™ 1
|
Characterisation
Analysis of Undifferentiated Cells
Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles |
NANOG |
Yes |
|
|
Differentiation Potency
In vitro spontaneous differentiation
In vitro directed differentiation
Genotyping
Karyotyping (Cell Line) |
|
Has the cell line karyotype been analysed? |
Yes
Normal
|
Other Genotyping (Cell Line) |
Login to share your feedback, experiences or results with the research community.